Metabolic and Bone Pharmacology

• Toxicology
  • Regulatory
  • Discovery
  • Stem Cell
  • Botulinum
  • Investigative-Special-Custom
• Pharmacokinetics
• Pharmacology
  • Ocular
  • Cardiovascular
  • Inflammation
  • Atherosclerosis
  • Arthritis-Immune Mediated
  • Metabolic and Bone
  • Anti-infective
  • Oncology
  • Stem Cell
  • Botulinum
  • Surgical-Custom-Special
• Dermatology
  • Toxicology Studies
  • Pharmacokinetics or Bioavailability Studies
  • Pharmacology and Efficacy Studies
• Ocular
  • Ocular Toxicology
  • Ophthlamic Pharmacokinetics
  • Ophthlamic Pharmacology & In Vivo
• Stem Cells
• Botulinum
• Veterinary
• Biocompatibility and Devices
• Histopathology
  • Laboratory Capabilities
  • Histochemical Staining
  • Pathology
  • Confocal Microscopy
  • Toxicology
  • Tissue Cross Reactivity
  • Immunohistochemistry
  • Devices, plastics, ground sections
  • Histomorphometry
  • Specialized Histology
  • Submitting a Study
  • Fee Schedule
  • Slide Gallery
• About CBI
  • Management Team
  • Scientific Advisors
  • Mission
  • Careers
  • Partners
  • Contact Us
• Events
• News
• Publications

Metabolic disorders including diabetes, obesity and osteoporosis are serious disorders of unmet medical need. CBI offers models for Type I, Type II diabetes, obesity, and osteoporosis.

• Streptozotocin-Induced Type I Diabetes in Rats
• DbDb Mice
• Zucker Lean and Fat Rats
• Hyperlipidemia in mice, rats and rabbits
• Osteoporosis in ovariectomized rats

For more information, contact CBI.